These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32906001)

  • 1. Chitosan-coated nanostructured lipid carriers of fenofibrate with enhanced oral bioavailability and efficacy.
    Pyo YC; Tran P; Kim DH; Park JS
    Colloids Surf B Biointerfaces; 2020 Dec; 196():111331. PubMed ID: 32906001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of Nanostructured Lipid Carriers of Fenofibrate Using a Box-Behnken Design for Oral Bioavailability Enhancement.
    Wang H; Hong W; Li X; Jin Q; Ye W; Feng Y; Huang B; Tai Z; Chen L; Li Z; Wang Y; Yang Y; Gao C; Gong W; Yang M
    Curr Drug Deliv; 2022; 19(7):773-787. PubMed ID: 33902411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
    Noor NM; Sheikh K; Somavarapu S; Taylor KMG
    Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of fenofibrate-loaded nanostructured lipid carriers for oral bioavailability enhancement.
    Tran TH; Ramasamy T; Truong DH; Choi HG; Yong CS; Kim JO
    AAPS PharmSciTech; 2014 Dec; 15(6):1509-15. PubMed ID: 25035071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
    Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
    J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan coated nanostructured lipid carriers for enhanced in vivo efficacy of albendazole against Trichinella spiralis.
    Eid RK; Ashour DS; Essa EA; El Maghraby GM; Arafa MF
    Carbohydr Polym; 2020 Mar; 232():115826. PubMed ID: 31952620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of S(+)-zaltoprofen oral bioavailability using nanostructured lipid carrier system.
    Pham TMA; Lee DH; Na YG; Jin M; Jung M; Kim HE; Yoo H; Won JH; Lee JY; Baek JS; Han SC; Lee HK; Cho CW
    Arch Pharm Res; 2022 Nov; 45(11):822-835. PubMed ID: 36307644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation.
    Khan S; Baboota S; Ali J; Narang RS; Narang JK
    Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization, and
    Saghafi Z; Mohammadi M; Mahboobian MM; Derakhshandeh K
    Drug Dev Ind Pharm; 2021 Mar; 47(3):509-520. PubMed ID: 33650445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks.
    Elmowafy M; Ibrahim HM; Ahmed MA; Shalaby K; Salama A; Hefesha H
    Drug Deliv; 2017 Nov; 24(1):932-941. PubMed ID: 28617150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipids-based nanostructured lipid carriers (NLCs) for improved oral bioavailability of sirolimus.
    Yu Q; Hu X; Ma Y; Xie Y; Lu Y; Qi J; Xiang L; Li F; Wu W
    Drug Deliv; 2016 May; 23(4):1469-75. PubMed ID: 27187522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
    Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
    Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
    Dudhipala N; Janga KY; Gorre T
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation, Characterization, and Pharmacokinetic Studies of 6-Gingerol-Loaded Nanostructured Lipid Carriers.
    Wei Q; Yang Q; Wang Q; Sun C; Zhu Y; Niu Y; Yu J; Xu X
    AAPS PharmSciTech; 2018 Nov; 19(8):3661-3669. PubMed ID: 30324361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan coated nanostructured lipid carriers (NLCs) for loading Vitamin D: A physical stability study.
    Rabelo RS; Oliveira IF; da Silva VM; Prata AS; Hubinger MD
    Int J Biol Macromol; 2018 Nov; 119():902-912. PubMed ID: 30063935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of ritonavir-loaded nanostructured lipid carriers employing quality by design (QbD) as a tool: characterizations, permeability, and bioavailability studies.
    Gurumukhi VC; Bari SB
    Drug Deliv Transl Res; 2022 Jul; 12(7):1753-1773. PubMed ID: 34671949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanostructured Lipid Carriers for Oral Bioavailability Enhancement of Exemestane: Formulation Design, In Vitro, Ex Vivo, and In Vivo Studies.
    Singh A; Neupane YR; Mangla B; Kohli K
    J Pharm Sci; 2019 Oct; 108(10):3382-3395. PubMed ID: 31201904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanostructured lipid carriers for the topical delivery of tretinoin.
    Ghate VM; Lewis SA; Prabhu P; Dubey A; Patel N
    Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation of Chitosan-Coated Piperine NLCs: Optimization, In Vitro Characterization, and In Vivo Preclinical Assessment.
    Zafar A; Alruwaili NK; Imam SS; Alsaidan OA; Alharbi KS; Yasir M; Elmowafy M; Mohammed EF; Al-Oanzi ZH
    AAPS PharmSciTech; 2021 Aug; 22(7):231. PubMed ID: 34477999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethyl oleate-containing nanostructured lipid carriers improve oral bioavailability of trans-ferulic acid ascompared with conventional solid lipid nanoparticles.
    Zhang Y; Li Z; Zhang K; Yang G; Wang Z; Zhao J; Hu R; Feng N
    Int J Pharm; 2016 Sep; 511(1):57-64. PubMed ID: 27374194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.